The independent source for health policy research, polling, and news.
KFF’s policy research provides facts and analysis on a wide range of policy issues and public programs.
KFF designs, conducts and analyzes original public opinion and survey research on Americans’ attitudes, knowledge, and experiences with the health care system to help amplify the public’s voice in major national debates.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the organization’s core operating programs.
COVID-19 vaccine uptake among adolescents ages 12-17 has slowed after an initial wave of enthusiasm over the summer, with half (49%) of parents saying their adolescent has received at least one dose, a new KFF COVID-19 Vaccine Monitor report reveals. The share is little changed since earlier in the fall.
This report updates parents' intentions for vaccinating their children, against COVID-19, as well as their views and concerns about vaccine safety, whether their schools encourage vaccination, and how the pandemic has affected their children, mental health, and ability to afford necessities.
As of December 5, 16.7% of 5-11 year-olds had received at least one COVID-19 vaccine dose with 4.3% of children reaching full vaccination, according to a new KFF analysis.
This data note provides an analysis of COVID-19 vaccination rates among 5-11 year-old children across the states. Overall, we find wide variation in share of children who have received at least one dose of a COVID-19 vaccine across the states.
The National Association of Black Journalists has recognized KFF’s Kaiser Health News and two of its editorial partners with a 2021 “Salute to Excellence” award for a radio story about how children are taught to cope and survive in communities beset by gun violence.
As states expand COVID-19 vaccination efforts to reach newly eligible children ages 5 to 11, a new KFF analysis highlights several tools state Medicaid programs have at their disposal to increase access to, and take up of, vaccines among lower-income children.
Following the recent US Food & Drug Administration’s (FDA) authorization and the Centers for Disease Control and Prevention’s (CDC) recommendation, children ages 5-11 are now eligible to receive Pfizer-BioNTech’s COVID-19 vaccine. There may be unique challenges to vaccinating young children, particularly those from low-income families who may face additional barriers to access. State Medicaid programs and Medicaid managed care plans are looking at a range of policy options to facilitate access to vaccines for young, low-income children.
This brief examines characteristics of uninsured children in 2020 and discusses how current policy proposals, including outreach efforts, continuous eligibility requirements, and closing the coverage gap, could affect children’s health coverage. Recent efforts to expand coverage for adults could benefit children’s coverage, especially for children in non-expansion states if the coverage gap is filled as proposed by the Build Back Better Act (BBBA).
In this Axios column, Drew Altman examines the data about what parents say they will do once their children ages 5-11 become eligible for a COVID-19 vaccine, and why it will take some time and a concerted outreach effort to match adult vaccination rates.
This report tracks the public's COVID-19 vaccine intentions, including parents' intentions for their children ages 5-11 who may soon become eligible to get a vaccine. It also examines workers' experiences with and views toward employer vaccine mandates and the public's holiday plans heading into the second holiday season under the pandemic.
© 2025 KFF